These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25745679)

  • 1. Author's reply: To PMID 24411550.
    Qureshi MS
    J Coll Physicians Surg Pak; 2015 Jan; 25(1):78-9. PubMed ID: 25745679
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effective treatment of genotype-3 chronic hepatitis C.
    Akhtar MA
    J Coll Physicians Surg Pak; 2015 Jan; 25(1):78. PubMed ID: 25604377
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009.
    Gelderblom HC; Beld MG
    J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection fighters. Hepatitis C--is a cure possible?
    TreatmentUpdate; 2005; 17(1):8-9. PubMed ID: 17225319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hepatitis C. Different modalities based on viral genotype].
    Pariente A
    Rev Prat; 2003 Jun; 53(11):1175-6. PubMed ID: 15185639
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
    Pérez Mota A; Graus J; García Flores MA; Blanco M; Pérez-Muñoz C; Villalgordo C; Rodero R
    Rev Esp Enferm Dig; 2003 Mar; 95(3):238-9. PubMed ID: 12760714
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries.
    Ceylan B; Arslan F; Yardimci C; Fincanci M; Özgüneş N
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):493-4. PubMed ID: 24598385
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of glomerulonephritis associated with hepatitis C virus in patient with cirrhosis: only pegylated interferon and ribavirin.
    Taş A; Koçak E; Akbal E; Köklü S
    Chin Med J (Engl); 2011 May; 124(10):1600. PubMed ID: 21740828
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C.
    el-Sayed AM; Sharara AI
    J Med Liban; 2001; 49(2):71-7. PubMed ID: 11910970
    [No Abstract]   [Full Text] [Related]  

  • 12. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of hepatitis C virus RNA].
    Ohishi W; Chayama K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):214-8. PubMed ID: 15359795
    [No Abstract]   [Full Text] [Related]  

  • 14. SEN viruses and treatment response in chronic hepatitis C virus.
    Naoumov NV
    Lancet; 2002 May; 359(9319):1779-80; author reply 1780. PubMed ID: 12049896
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protocol for the treatment of chronic viral hepatitis].
    Dalmi L; Gervain J; Horváth G; Hunyady B; Ibrányi E; Makara M; Pár A; Szalay F; Tornai I; Telegdy L; ;
    Orv Hetil; 2008 Jan; 149(3):129-35. PubMed ID: 18194921
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-infections. Predicting recovery from hep C.
    TreatmentUpdate; 2008; 20(4):10-1. PubMed ID: 19248276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current state of antiviral chemotherapy (author's transl)].
    Dussaix E; Tournier P
    Ann Pediatr (Paris); 1979 Nov; 26(9):591-4. PubMed ID: 95514
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the role of sofosbuvir in treating hepatitis C infection?
    Carey L
    JAAPA; 2015 Feb; 28(2):16-9. PubMed ID: 25621961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 20. Has genetics eradicated the good old predictors of hepatitis C treatment response?
    Pawlotsky JM
    Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):157-8. PubMed ID: 21492738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.